-
Busulfan for Injection
SteriMax is pleased to announce the launch of Busulfan. To learn more visit the Busulfan product page. -
SteriMax New Product Acquisition
SteriMax is pleased to announce the acquisition of the following products from Valeant Canada effective December 1st, 2017. -
Furosemide for Injection
SteriMax is pleased to announce the launch of Furosemide for Injection. To learn more visit the Furosemide product page. -
Bupivacaine Injection BP
SteriMax is pleased to announce the launch of Bupivacaine Injection BP. To learn more visit the Bupivacaine product page. -
Diclofenac 1.5% w/w
SteriMax is pleased to announce the launch of Diclofenac 1.5% w/w. To learn more visit the Diclofenac product page. -
Piperacillin and Tazobactam for Injection 40.5 g
SteriMax is pleased to announce the launch of Piperacillin and Tazobactam for Injection 40.5 g. To learn more visit the Piperacillin and Tazobactam for Injection product page. -
cefTAZidime Launches
SteriMax is pleased to announce the launch of cefTAZidime for Injection BP in 1 g, 2 g, 3 g, and 6 g strengths. To learn more visit the cefTAZidime for Injection product page. -
Phenytoin Launches
SteriMax is pleased to announce the launch of Phenytoin for Injection in 2 mL and 5 mL strengths. To learn more visit the Phenytoin product page. -
Tranexamic Acid 500mg Tablets now available!
Sterimax has launched the first Canadian generic Tranexamic Acid 500mg Tablets! To learn more visit the Tranexamic Acid page. -
SteriMax has launched Pilocarpine 5mg tablets.
Sterimax is pleased to announce the launch of Pilocarpine Hydrochloride 5mg Tablets. To learn more visit the Pilocarpine page.
12